These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33851351)

  • 1. Transforming ATTR cardiac amyloidosis into a chronic disease: The enormous potential of quantitative SPECT to improve diagnosis, prognosis, and monitoring of disease progression.
    Ayers MP; Peruri AV; Bourque JM
    J Nucl Cardiol; 2021 Oct; 28(5):1846-1850. PubMed ID: 33851351
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy.
    Rettl R; Wollenweber T; Duca F; Binder C; Cherouny B; Dachs TM; Camuz Ligios L; Schrutka L; Dalos D; Beitzke D; Loewe C; Badr Eslam R; Kastner J; Hacker M; Bonderman D
    Eur Heart J Cardiovasc Imaging; 2023 Jul; 24(8):1019-1030. PubMed ID: 36881774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
    Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
    JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
    Griffin JM; Maurer MS
    Trends Cardiovasc Med; 2021 Jan; 31(1):59-66. PubMed ID: 31889610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of transthyretin-related amyloidosis cardiomyopathy.
    Teng C; Li P; Bae JY; Pan S; Dixon RAF; Liu Q
    Clin Cardiol; 2020 Nov; 43(11):1223-1231. PubMed ID: 32725834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of transthyretin amyloidosis in patients with established cardiomyopathy.
    Martín-Álvarez E; Larrañaga-Moreira JM; Barge-Caballero G; Souto-Caínzos B; Crepo-Leiro MG; Barriales-Villa R
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):347-349. PubMed ID: 38043734
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
    Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
    Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
    Maurer MS; Bokhari S; Damy T; Dorbala S; Drachman BM; Fontana M; Grogan M; Kristen AV; Lousada I; Nativi-Nicolau J; Cristina Quarta C; Rapezzi C; Ruberg FL; Witteles R; Merlini G
    Circ Heart Fail; 2019 Sep; 12(9):e006075. PubMed ID: 31480867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
    Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
    J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.
    Papathanasiou M; Carpinteiro A; Kersting D; Jakstaite AM; Hagenacker T; Schlosser TW; Rischpler C; Rassaf T; Luedike P
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1581. PubMed ID: 33345470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.
    Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative ATTR-cardiac amyloidosis SPECT/CT imaging: The time is now!
    Auer B; Kijewski MF; Dorbala S
    J Nucl Cardiol; 2023 Jun; 30(3):1246-1249. PubMed ID: 37138175
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis.
    Masri A; Bukhari S; Ahmad S; Nieves R; Eisele YS; Follansbee W; Brownell A; Wong TC; Schelbert E; Soman P
    Circ Cardiovasc Imaging; 2020 Feb; 13(2):e010249. PubMed ID: 32063053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
    Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis.
    Akatsuka T; Fujimoto N; Ishiyama M; Nakamori S; Imanaka-Yoshida K; Dohi K
    ESC Heart Fail; 2021 Aug; 8(4):3422-3426. PubMed ID: 34145794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis.
    Wehbe RM; Kansal P; Holly TA
    J Nucl Cardiol; 2021 Apr; 28(2):653-660. PubMed ID: 32383085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.